
1. Genes (Basel). 2021 Oct 28;12(11). pii: 1731. doi: 10.3390/genes12111731.

Study of Quasispecies Complexity and Liver Damage Progression after Liver
Transplantation in Hepatitis C Virus Infected Patients.

Llorens-Revull M(1)(2)(3), Gregori J(1)(2)(4), Dopazo C(2)(5), Rodriguez-Frías
F(2)(3)(6), Garcia-Cehic D(1)(2), Soria ME(1), Chen Q(1), Rando A(6), Perales
C(1)(2), Esteban JI(1)(2)(7), Quer J(1)(2)(3), Bilbao I(2)(5)(8).

Author information: 
(1)Liver Diseases-Viral Hepatitis, Liver Unit, Vall d'Hebron Institut de Recerca 
(VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital
Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.
(2)Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y
Digestivas (CIBERehd), Instituto de Salud Carlos III, Av. Monforte de Lemos, 3-5,
28029 Madrid, Spain.
(3)Biochemistry, Molecular Biology, Universitat Autònoma de Barcelona (UAB),
Campus de la UAB, Plaça Cívica, 08193 Bellaterra, Spain.
(4)Roche Diagnostics SL, Avinguda de la Generalitat, 171-173, 08174 Sant Cugat
del Vallès, Spain.
(5)Hepatobiliopancreatic Surgery and Transplant Unit, Vall d'Hebron Institut de
Recerca (VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona
Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.
(6)Biochemistry and Microbiology Departments, Vall d'Hebron Institut de Recerca
(VHIR), Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital
Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.
(7)Medicine, Universitat Autònoma de Barcelona (UAB), Campus de la UAB, Plaça
Cívica, 08193 Bellaterra, Spain.
(8)Surgery, Universitat Autònoma de Barcelona (UAB), Campus de la UAB, Plaça
Cívica, 08193 Bellaterra, Spain.

Cirrhosis derived from chronic hepatitis C virus (HCV) infection is still a
common indication for liver transplantation (LT). Reinfection of the engrafted
liver is universal in patients with detectable viral RNA at the time of
transplant and causes fast progression of cirrhosis (within 5 years) in around
one-third of these patients. To prevent damage to the liver graft, effective
direct-acting antiviral (DAA) therapy is required as soon as possible. However,
because of post-LT clinical instability, it is difficult to determine the optimal
time to start DAAs with a low risk of complications. Evaluate changes in
quasispecies complexity following LT and seek a predictive index of fast liver
damage progression to determine the timing of DAA initiation. HCV genomes
isolated from pre-LT and 15-day post-LT serum samples of ten patients, who
underwent orthotopic LT, were quantified and sequenced using a next-generation
sequencing platform. Sequence alignments, phylogenetic trees, quasispecies
complexity measures, biostatistics analyses, adjusted R2 values, and analysis of 
variance (ANOVA) were carried out. Three different patterns of reinfection were
observed (viral bottlenecking, conserved pre-LT population, and mixed
populations), suggesting that bottlenecking or homogenization of the viral
population is not a generalized effect after liver graft reinfection. None of the
quasispecies complexity measures predicted the future degree of liver damage.
Higher and more uniform viral load (VL) values were observed in all pre-LT
samples, but values were more dispersed in post-LT samples. However, VL increased
significantly from the pre-LT to 15-day post-LT samples in patients with advanced
fibrosis at 1-year post-LT, suggesting that a VL increase on day 15 may be a
predictor of fast liver fibrosis progression. HCV kinetics after LT differ
between patients and are not fibrosis-dependent. Higher VL at day 15 post-LT
versus pre-LT samples may predict fast liver fibrosis progression.

DOI: 10.3390/genes12111731 
PMCID: PMC8625210
PMID: 34828337 

